Optimi Health Announces Launch of Psilocybin Capsules in Australia for Treatment-Resistant DepressionExport of 1,000 natural psilocybin capsules for prescription use under Australia's Authorised Prescriber Scheme follows the Company's successful launch of MDMA sales in 2024September 03, 2025 7:30 AM EDT | Source: Optimi Health Corp.Vancouver, British Columbia--(Newsfile Corp. - September 3, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadia ...